BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 9479576)

  • 1. Protein sorting within the MHC class II antigen-processing pathway.
    Marks MS
    Immunol Res; 1998; 17(1-2):141-54. PubMed ID: 9479576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The bio-logical role of invariant chain (Ii) in MHC class II antigen presentation.
    Nordeng TW; Bakke O
    Immunol Lett; 1994 Dec; 43(1-2):47-55. PubMed ID: 7737689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of human CD4+ T cells by targeting MHC class II epitopes to endosomal compartments using human CD1 tail sequences.
    Niazi KR; Ochoa MT; Sieling PA; Rooke NE; Peter AK; Mollahan P; Dickey M; Rabizadeh S; Rea TH; Modlin RL
    Immunology; 2007 Dec; 122(4):522-31. PubMed ID: 17635609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Compartmentalization of class II antigen presentation: contribution of cytoplasmic and endosomal processing.
    Li P; Gregg JL; Wang N; Zhou D; O'Donnell P; Blum JS; Crotzer VL
    Immunol Rev; 2005 Oct; 207():206-17. PubMed ID: 16181338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endosomal localization of MHC class II-invariant chain complexes.
    Miller J
    Immunol Res; 1994; 13(4):244-52. PubMed ID: 7616052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intracellular traffic to compartments for MHC class II peptide loading: signals for endosomal and polarized sorting.
    Bakke O; Nordeng TW
    Immunol Rev; 1999 Dec; 172():171-87. PubMed ID: 10631946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of endogenous peptide-major histocompatibility complex class II complexes derived from invariant chain-antigen fusion proteins.
    Sanderson S; Frauwirth K; Shastri N
    Proc Natl Acad Sci U S A; 1995 Aug; 92(16):7217-21. PubMed ID: 7638170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Downmodulation of antigen presentation by H2-O in B cell lines and primary B lymphocytes.
    Brocke P; Armandola E; Garbi N; Hämmerling GJ
    Eur J Immunol; 2003 Feb; 33(2):411-21. PubMed ID: 12645938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MHC class II restricted antigen presentation.
    Pieters J
    Curr Opin Immunol; 1997 Feb; 9(1):89-96. PubMed ID: 9039772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intracellular organelles involved in antigen processing and the binding of peptides to class II MHC molecules.
    Harding CV
    Semin Immunol; 1995 Dec; 7(6):355-60. PubMed ID: 8775461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of subcellular organelles involved in major histocompatibility complex (MHC) class II-restricted antigen presentation by electrophoresis.
    Engering A; Lefkovits I; Pieters J
    Electrophoresis; 1997 Dec; 18(14):2523-30. PubMed ID: 9527480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficient internalization of MHC class II-invariant chain complexes is not sufficient for invariant chain proteolysis and class II antigen presentation.
    Swier K; Miller J
    J Immunol; 1995 Jul; 155(2):630-43. PubMed ID: 7608541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytosolic targeting of hen egg lysozyme gives rise to a short-lived protein presented by class I but not class II major histocompatibility complex molecules.
    Calin-Laurens V; Forquet F; Mottez E; Kanellopoulos J; Godeau F; Kourilsky P; Gerlier D; Rabourdin-Combe C
    Eur J Immunol; 1991 Mar; 21(3):761-9. PubMed ID: 2009914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Capture and processing of exogenous antigens for presentation on MHC molecules.
    Watts C
    Annu Rev Immunol; 1997; 15():821-50. PubMed ID: 9143708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MHC class II compartments: specialized organelles of the endocytic pathway in antigen presenting cells.
    Pieters J
    Biol Chem; 1997 Aug; 378(8):751-8. PubMed ID: 9377469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antigen presentation by MHC class II molecules: invariant chain function, protein trafficking, and the molecular basis of diverse determinant capture.
    Castellino F; Zhong G; Germain RN
    Hum Immunol; 1997 May; 54(2):159-69. PubMed ID: 9297534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional and ultrastructural evidence for intracellular formation of major histocompatibility complex class II-peptide complexes during antigen processing.
    Harding CV; Unanue ER; Slot JW; Schwartz AL; Geuze HJ
    Proc Natl Acad Sci U S A; 1990 Jul; 87(14):5553-7. PubMed ID: 2371288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polarized transport of MHC class II molecules in Madin-Darby canine kidney cells is directed by a leucine-based signal in the cytoplasmic tail of the beta-chain.
    Simonsen A; Pedersen KW; Nordeng TW; von der Lippe A; Stang E; Long EO; Bakke O
    J Immunol; 1999 Sep; 163(5):2540-8. PubMed ID: 10452991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of MHC class II-presented peptides generated from an antigen targeted to different endocytic compartments.
    Fernandes DM; Vidard L; Rock KL
    Eur J Immunol; 2000 Aug; 30(8):2333-43. PubMed ID: 10940924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Processing and MHC class II presentation of exogenous soluble antigen involving a proteasome-dependent cytosolic pathway in CD40-activated B cells.
    Becker HJ; Kondo E; Shimabukuro-Vornhagen A; Theurich S; von Bergwelt-Baildon MS
    Eur J Haematol; 2016 Aug; 97(2):166-74. PubMed ID: 26561366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.